8158 — China Regenerative Medicine International Share News
0.000.00%
Last trade - 00:00- HK$66.94m
- HK$103.36m
- HK$72.06m
Brief: China Regenerative Medicine International Expects FY Loss Attributable
Brief: China Regenerative Medicine International Appoints Ray Yip As Chairman
Brief: China Regenerative Medicine International Appoints Wang Xuejun As CEO
Brief: China Regenerative Medicine International Says Unit Gets Nod To Set Up Shenzhen Tissue Engineering Laboratory
Brief: China Regenerative Medicine International Qtrly Loss Attributable HK$134.9 Million
Brief: China Regenerative Medicine International Says Chen Chunguo Resigned As CEO
Brief: China Regenerative Medicine International Says Cui Zhanfeng Will Resign As Chairman
Brief: China Regenerative Medicine International Posts Q1 Loss Attributable HK$53.4 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable To Owners Of Co Of HK$158.5 Mln
Brief: China Regenerative Medicine Informed That All Favour Intends To Dispose 2 Bln Shares Of Co
Brief: Baolingbao Biology's Unit Signs Agreement To Acquire 11.4 Pct Stake In China Regenerative Medicine
Brief: China Regenerative Medicine International Says Substantial Shareholder Ups Stake In Co
Brief: China Regenerative Medicine International Entered Agreement With Shanghai Lingang Songjiang High-Tech Industry Development
Brief: China Regenerative Medicine International To By Lung Hang Investments For HK$3.6 Bln-HK$$3.8 Bln
Brief: China Regenerative Medicine International Says Qtrly Revenue Hk$89 Million
Brief: China Regenerative Medicine International Says Wong Sai Hung Resigned As Vice-Chairman
Brief: Valeant completes sale of Obagi Medical products business to Haitong International Zhongua Finance Acquisition Fund I, L.P.
Brief: China Regenerative Medicine International says unit to sell Shaanxi Aimiya to third party
Brief: China Regenerative Medicine International say Dai Yumin acquired 40 pct stake in All Favour